EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.1.2.3 | additional information | enzyme phosphorylation by anaplastic lymphoma kinase enhances enzymatic activity and dampens the methotrexate-mediated transformylase activity inhibition | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.1.2.3 | methotrexate | enzyme phosphorylation dampens the methotrexate-mediated transformylase activity inhibition | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.10 | 5-formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide + H2O | Homo sapiens | catalyzation of the final two steps of de novo purine biosynthesis pathway | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.2.3 | Homo sapiens | P31939 | bifunctional 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | - |
3.5.4.10 | Homo sapiens | P31939 | - |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
2.1.2.3 | phosphoprotein | bifunctional 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase associates with nucleoplasmin-anaplastic lymphoma kinase, and its phosphorylation requires anaplastic lymphoma kinase activity. Phosphorylation enhances enzymatic activity and dampens the methotrexate-mediated transformylase activity inhibition | Homo sapiens |
3.5.4.10 | phosphoprotein | phophorylation increases enzyme activity | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.2.3 | CCRF-CEM cell | - |
Homo sapiens | - |
2.1.2.3 | JURKAT cell | - |
Homo sapiens | - |
2.1.2.3 | Mac-1 cell | - |
Homo sapiens | - |
2.1.2.3 | SUP-M2 cell | - |
Homo sapiens | - |
2.1.2.3 | Sup-M2-TS cell | - |
Homo sapiens | - |
3.5.4.10 | anaplastic large cell lymphoma cell | ALCL cell line TS, Sup-M2 cells, JB-6 cells, SU-DHL1 cells | Homo sapiens | - |
3.5.4.10 | CCRF-CEM cell | - |
Homo sapiens | - |
3.5.4.10 | HEK-293T cell | immunoprecipitated from | Homo sapiens | - |
3.5.4.10 | JURKAT cell | - |
Homo sapiens | - |
3.5.4.10 | KARPAS-299 cell | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.5.4.10 | additional information | - |
proteomic approach to identify phophorylated proteins with a pathogenic role in transformation mediated by anaplastic lymphoma kinase (ALK), profiling of tyrosine-phosphorylation, mass spectrometry, anti-phosphotyrosine protein immunoprecipitation, posttranslational modification of the bifunctional 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) formyltransferase/inosine monophosphate (IMP) cyclohydrolase (AICAR-FT/IMP-CHase, ATIC) by phosphorylation, enzyme is a direct target of anaplastic lymphoma kinase (ALK), phoshorylation increases enzyme activity posttranslational modification of a key purine synthesis enzyme | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.10 | 5-formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide + H2O | catalyzation of the final two steps of de novo purine biosynthesis pathway | Homo sapiens | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.4.10 | AICAR-FT/IMP-CHase | - |
Homo sapiens |
3.5.4.10 | ATIC | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.5.4.10 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.4.10 | 7.5 | - |
assay at | Homo sapiens |